NeuroSense Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NRSN and other ETFs, options, and stocks.

About NRSN

Neurosense Therapeutics Ltd. is a clinical-stage biotechnology company, which engages n the discovery and development of targeted therapeutics for neurodegenerative diseases. The firm offers PrimeC, a therapy for amyotrophic lateral sclerosis (ALS). 

CEO
Alon Ben-Noon
CEOAlon Ben-Noon
Employees
15
Employees15
Headquarters
Herzliya, Tel Aviv
HeadquartersHerzliya, Tel Aviv
Founded
2017
Founded2017
Employees
15
Employees15

NRSN Key Statistics

Market cap
53.25M
Market cap53.25M
Price-Earnings ratio
-3.77
Price-Earnings ratio-3.77
Dividend yield
—
Dividend yield—
Average volume
521.09K
Average volume521.09K
High today
$2.32
High today$2.32
Low today
$2.09
Low today$2.09
Open price
$2.24
Open price$2.24
Volume
190.33K
Volume190.33K
52 Week high
$2.60
52 Week high$2.60
52 Week low
$0.512
52 Week low$0.512

People also own

Based on the portfolios of people who own NRSN. This list is generated using Robinhood data, and it’s not a recommendation.
Mullen Automotive
Plug Power
BigBear.ai
Rigetti Computing
SoundHound AI
SoFi Technologies
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.